{"disease":{"id":"cystic-fibrosis-gastrointestinal-disease","name":"cystic fibrosis gastrointestinal disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05253859","title":"CFTR Modulators and Gastrointestinal Complications","phase":"","overall_status":"COMPLETED","enrollment_count":47023,"lead_sponsor_name":"Nottingham University Hospitals NHS Trust","has_results":false},{"nct_id":"NCT04602468","title":"Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER)","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":237,"lead_sponsor_name":"Royal College of Surgeons, Ireland","has_results":false},{"nct_id":"NCT06084468","title":"Cardiac Structure and Function in Patients with Cystic Fibrosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":104,"lead_sponsor_name":"Herlev and Gentofte Hospital","has_results":false},{"nct_id":"NCT04392544","title":"Intestinal Inflammation in CF Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false},{"nct_id":"NCT04302662","title":"Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"AzurRx SAS","has_results":false},{"nct_id":"NCT04210427","title":"Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"St. Louis University","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}